Publication | Closed Access

New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids

New Efficient ArtemisininAntiparasitic AgentMedicineImmunologyHuman Leukemia CellsAnti-cancer AgentDrug DevelopmentPlasmodium FalciparumPharmacologyAntiviral CompoundDrug Discovery